In this study, region-2 of the EFEMP1 promoter was more frequently methylated than region-1, and the aberrant methylation tended to spread from region-2 toward region-1 with IPMN progression. This evidence concerns the gene EFEMP1 and pancreatic intraductal papillary-mucinous neoplasm.